L-asparaginase, which mainly catalyzes the hydrolysis of L-asparagine to L-aspartic acid, is one of the standard drugs for treatment of acute lymphoblastic leukemia (ALL). This evidence concerns the gene ASPG and acute lymphoblastic leukemia.